Aberrant cytoplasmic localization of MLH1 characterizes a sub-clonal breast cancer cell population that seeds recurrence
A. Mazumder, T. DeWitt, E. Oropeza, N. Punturi, D. Lozano, E. Sajjadi, E. Guerini-Rocco, K. Venetis, M. Ivanova, E. Mane, N. Fusco, S. Haricharan
This study identifies aberrant cytoplasmic MLH1 localization in sub-clonal breast cancer cells as a driver of endocrine resistance, showing it predicts response to CDK4/6 inhibitors.
bioRxiv · Feb 27, 2024 · PreprintCancer Biology